EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive accuracy of population meropenem models in critically ill pneumonia patients

Adrian Valadez iD, Emma Harlan, Colin Jeantet, Marc H Scheetz iD, Michael N Neely iD, Helen K Donnelly iD, Richard G Wunderink, Nathaniel J Rhodes iD

Antimicrobial Agents and Chemotherapy · 05.08.2026 · 70 (8)

DOI: 10.1128/aac.00458-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.08.2026. Verfasst von Adrian Valadez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Midwestern University, College of Pharmacy, Downers Grove, Illinois, USA. Hauptthemen laut MEDLINE: Meropenem, Anti-Bacterial Agents, Pneumonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Population pharmacokinetic (PK) models may not generalize across critically ill populations. We evaluated the transportability of published parametric and nonparametric meropenem models as Bayesian priors. Seven published meropenem models were implemented in Monolix 2024R1. Nonparametric models were converted to log-normal priors from reported medians and CV%. An independent cohort was used for evaluation. A priori and a posteriori predictions were summarized across eligible observations and separately for observations obtained during continuous renal replacement therapy (CRRT) and in the absence of CRRT. Predictive performance was assessed using relative mean prediction error (rMPE) and relative median absolute prediction error (rMdAPE). An rMPE within ±20% and an rMdAPE ≤30% were defined as acceptable. Seventeen patients, including six receiving CRRT, contributed 74 plasma concentrations. In the pooled cohort, only the Rohani and Shekar models met predefined performance thresholds at both population and individual levels ( a priori rMdAPE 24.6%–26.4%; a posteriori rMdAPE 6.7%–11.1%). In CRRT patients, no model achieved acceptable a priori performance; after Bayesian updating, all CRRT-specified models met accuracy and precision criteria, with the nonparametric models (Reed and Rohani) demonstrating low imprecision. In non-CRRT patients, several models showed population-level bias, but all met predefined accuracy and precision thresholds after Bayesian updating. Among evaluated models, Rohani, Reed, and Shekar demonstrated the most consistent predictive performance across the CRRT and non-CRRT subgroups. Nonparametric model summaries can be translated into parametric priors, but model selection remains critical when applying Bayesian dosing in critically ill patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeropenemAnti-Bacterial AgentsPneumoniaHumansCritical IllnessBayes TheoremFemaleAgedMaleMiddle AgedContinuous Renal Replacement TherapyModels, Biological

Stichwörter der Autor:innen

bayesian modelexternal validationpharmacokineticspneumoniarenal replacement

Substanzen

MeropenemAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Midwestern University, College of Pharmacy, Downers Grove, Illinois, USA.
  • Pharmacometrics Center of Excellence, Midwestern University, Downers Grove, Illinois, USA.
  • Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.
  • Department of Biomedical Sciences, College of Graduate Studies, Midwestern University, Downers Grove, Illinois, USA.
  • Department of Pharmacology, College of Graduate Studies, Midwestern University, Downers Grove, Illinois, USA.
  • Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Adrian Valadez, Marc H Scheetz, Michael N Neely, Helen K Donnelly, Nathaniel J Rhodes

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NLM NIH HHS
  • National Institutes of Health

Zitieren

APA

Valadez, A., Harlan, E., Jeantet, C., Scheetz, M. H., Neely, M. N., Donnelly, H. K., Wunderink, R. G., & Rhodes, N. J. (2026). Predictive accuracy of population meropenem models in critically ill pneumonia patients. Antimicrobial Agents and Chemotherapy, 70(8). https://doi.org/10.1128/aac.00458-26

Vancouver

Valadez A, Harlan E, Jeantet C, Scheetz MH, Neely MN, Donnelly HK, et al. Predictive accuracy of population meropenem models in critically ill pneumonia patients. Antimicrobial Agents and Chemotherapy. 2026;70(8). doi:10.1128/aac.00458-26

BibTeX
@article{Valadez2026,
  author = {Valadez, Adrian and Harlan, Emma and Jeantet, Colin and Scheetz, Marc H and Neely, Michael N and Donnelly, Helen K and Wunderink, Richard G and Rhodes, Nathaniel J},
  title = {Predictive accuracy of population meropenem models in critically ill pneumonia patients},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {8},
  doi = {10.1128/aac.00458-26}
}
Kostenlos starten →